Auxly Cannabis Group Inc.

TSX:XLY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.53 +0.00%

+$0.00 today

Market cap
$364.42M
Beta
1.16
P/E (TTM)
7.3
EPS (TTM)
$0.02
52W Low $0.08High $0.19

Volume 0.13M

Average 0.71M

XLY.TO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Auxly Cannabis Group Inc.TSX: XLY.TO

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 18.4%

Gross margin was 18.4% in Q1 FY2026, down 38.7 pp from a year earlier. On a trailing-twelve-month basis it was 47.5%, down 5.8 pp year over year. Over 3 fiscal years it widened by 39.8 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
18.4%-24.5 pp QoQ
Last fiscal yearDec 2025
57.3%+8.3 pp YoY
LTMMar 2026
47.5%-5.8 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-38.7 pp——
1 year+8.3 pp——
3 years+39.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
57.3%
Year-over-year change
+8.3pp

Gross Margin vs competitors

How XLY.TO compares with its peers on the latest reported figures

  • XLY.TO's LTM Mar 2026 gross margin of 47.5% is the 2nd highest of the 3 companies compared; the peer median is 44.1%.
  • Its year-over-year change of -5.8 pp is the 2nd highest of 3, against a peer median of -12.2 pp.
  • Over three fiscal years its change of +39.8 pp compares with a peer median of -26.6 pp.
XLY.TO Competitors Peer median
Gross Margin for XLY.TO and competitors
Company Period LTM level YoY 3-year change
HLS.TOHLS Therapeutics Inc.LTM Mar 202661.7% -21.3 pp-49.4 pp
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202647.5% -5.8 pp+39.8 pp
CRRX.TOCareRx CorporationLTM Mar 202626.5% -3.1 pp-3.8 pp
CRDL.TOCardiol Therapeutics Inc.FY2025— ——
Peer median (excluding XLY.TO) 44.1%-12.2 pp-26.6 pp

Competitors are the stored peer set for XLY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue83.83M94.47M101.08M122.33M151.48M
Cost of Revenue64.54M77.96M79.8M62.4M64.74M
Gross Profit19.29M16.51M21.28M59.93M86.74M
Gross Margin23.0%17.5%21.1%49.0%57.3%
Research & Development298K292K497K00
Selling, General & Admin45.42M50.38M40.28M40.73M49.07M
Operating Expenses58.23M65.49M47.23M45.22M54.07M
Depreciation & Amortization14.27M20.18M11.21M10.28M11.45M
EBITDA(18.3M)(94.79M)(10.89M)24.38M50.31M
EBITDA Margin-21.8%-100.3%-10.8%19.9%33.2%
Operating Income(38.94M)(48.98M)(25.95M)14.71M32.67M
Operating Margin-46.4%-51.8%-25.7%12.0%21.6%
Interest Income1.59M337K32K240K130K
Interest Expense17.67M21.58M25.65M14.46M6.34M
Other Income / Expenses(11.3M)(87.58M)(21.8M)(15.07M)(155K)
Income Before Tax(50.24M)(136.56M)(47.75M)(356K)32.52M
Pre-Tax Margin-59.9%-144.5%-47.2%-0.3%21.5%
Income Tax Expense(4.33M)(6.26M)(3.24M)15.99M(9.34M)
Net Income(33.74M)(130.29M)(44.51M)(16.35M)41.86M
Net Margin-40.2%-137.9%-44.0%-13.4%27.6%
EPS (Basic)(0.06)(0.15)(0.04)(0.01)0.03
EPS (Diluted)(0.06)(0.15)(0.04)(0.01)0.03
Weighted Avg Shares783.38M889.87M990.99M1.2B1.33B
Weighted Avg Shares (Diluted)783.38M889.87M990.99M1.2B1.59B

Auxly Cannabis Group Inc.

TSX:XLY.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.